InsidersTradesSigma
Discover the full record of transactions filed by Jeppe Øvli Øvlesen, 首席执行官. Director active across 2 companies, notably SynAct Pharma AB. In total, 1 reports have been published. Activity tracked since 5 March 2026. The latest transaction was filed on 5 March 2026 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Jeppe Øvli Øvlesen is the Chief Executive Officer of SynAct Pharma AB, a biopharmaceutical company. In his role, he is responsible for the strategic direction of the company and managing operations. Jeppe Øvli Øvlesen is committed to developing innovative treatments and improving patients' lives through SynAct Pharma's solutions.